PRESS RELEASE published on 06/24/2024 at 14:00, 2 months 24 days ago Biotest's sustainability campaign GoFuture part of the new documentary 'Future Seeds' Biotest AG's sustainability campaign GoFuture featured in the documentary 'Future Seeds', now available on Prime Video in twelve countries Documentary Biotest AG GoFuture Future Seeds Sustainability Campaign
BRIEF published on 06/17/2024 at 09:05, 3 months 1 day ago Biotest Achieves Milestone with FDA Approval for Yimmugo FDA Approval Yimmugo Biotest Immunodeficiencies Next Level Facility
BRIEF published on 06/17/2024 at 09:05, 3 months 1 day ago Biotest franchit une étape importante avec l'approbation de la FDA pour Yimmugo Approbation De La FDA Yimmugo Biotest Immunodéficiences Installation De Niveau Supérieur
PRESS RELEASE published on 06/17/2024 at 09:00, 3 months 1 day ago Milestone for Biotest: US approval for innovative immunoglobulin Yimmugo Biotest AG achieves US approval for intravenous immunoglobulin Yimmugo, marking a significant milestone and future sales growth in the global market Healthcare Innovation Biotest AG FDA Certification US Approval Immunoglobulin Yimmugo
BRIEF published on 05/07/2024 at 20:31, 4 months 11 days ago Biotest AG: Dividend Approval at Annual General Meeting Annual General Meeting Shareholder Approval Dividend Distribution Preference Shares Biotest AG
BRIEF published on 05/07/2024 at 20:31, 4 months 11 days ago Biotest AG : approbation du dividende lors de l'assemblée générale annuelle Assemblée Générale Annuelle Approbation Des Actionnaires Répartition Des Dividendes Partage De Préférence Biotest SA
PRESS RELEASE published on 05/07/2024 at 20:26, 4 months 11 days ago Biotest AG: Annual General Meeting approves dividend distribution Biotest AG's Annual General Meeting approves dividend distribution of EUR 0.04 per preference share for 2023 and 2022, with majority support. CEO Peter Janssen's speech available online Annual General Meeting Shareholders Dividend Distribution Biotest AG Peter Janssen
BRIEF published on 05/07/2024 at 09:05, 4 months 11 days ago Biotest AG annonce une croissance significative au premier trimestre 2024 Hausse Des Revenus Yimmugo Biotest SA Résultats Financiers Du Premier Trimestre 2024 Produits Plasmatiques
BRIEF published on 05/07/2024 at 09:05, 4 months 11 days ago Biotest AG Reports Significant Growth in Q1 2024 Revenue Growth Biotest AG Yimmugo Q1 2024 Financial Results Plasma Products
PRESS RELEASE published on 05/07/2024 at 09:00, 4 months 11 days ago Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024 Biotest AG reports a significant 83.6% increase in sales to Euro 215.2 million in the first quarter of 2024, driven by product sales and successful completion of the Fibrinogen study EBIT Sales Increase Biotest AG First Quarter 2024 Fibrinogen Study
Published on 09/19/2024 at 03:20, 46 minutes ago How to Sell a Business Online Guide for Small Business Owners Released by the Business Brokers Directory
Published on 09/18/2024 at 23:10, 4 hours 56 minutes ago Ur-Energy Provides Operations, Construction and 2024 Guidance Updates
Published on 09/18/2024 at 23:00, 5 hours 6 minutes ago Garden State Gold & Coin Applauds Passage of Historic NJ Sales Tax Bill on Precious Metals
Published on 09/18/2024 at 21:15, 6 hours 51 minutes ago New to the Street Launches 24-Part Series with ARAX Holdings, Spotlighting Core Blockchain, CorePass, Lunaº Mesh, and Revolutionary Tech Solutions
Published on 09/18/2024 at 21:00, 7 hours 6 minutes ago Falcon Commences Drilling At Its Great Burnt Copper Project, NL
Published on 09/18/2024 at 19:11, 8 hours 55 minutes ago EQS-Adhoc: alstria office REIT-AG: squeeze-out demand regarding the shares of minority shareholders, amendment to investment agreement, loss of REIT-status at year-end 2024
Published on 09/18/2024 at 18:45, 9 hours 21 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/18/2024 at 18:31, 9 hours 34 minutes ago EQS-Adhoc: Vonovia SE: Initiation of the process to conclude a domination and profit and loss transfer agreement between Vonovia SE and Deutsche Wohnen SE
Published on 09/18/2024 at 18:13, 9 hours 53 minutes ago BILENDI: Creating discussion guides for market research is now possible with AI, thanks to BARI and Bilendi Discuss
Published on 09/18/2024 at 17:21, 10 hours 44 minutes ago EQS-Adhoc: Marinomed Biotech AG resolves capital increase excluding statutory subscription rights by issuing 154,053 no-par value bearer shares at an issue price of EUR 5 per share
Published on 09/18/2024 at 18:45, 9 hours 20 minutes ago Augmentation de capital consécutive à l'attribution gratuite d'actions aux salariés du groupe EuropaCorp
Published on 09/18/2024 at 18:45, 9 hours 20 minutes ago Capital increase following the allocation of free shares to EuropaCorp employees
Published on 09/18/2024 at 17:40, 10 hours 26 minutes ago Groupe CRIT : Modalités de mise à disposition du Rapport Financier semestriel 2024.